Form 4: Amphastar Pharmaceuticals Executive Yakob Liawatidewi Reports Stock Disposals to Cover Tax Obligations
SEC Form 4 Filing
Yakob Liawatidewi, EVP Corp Admin Center at Amphastar Pharmaceuticals, reported disposing of shares to cover tax liabilities related to vesting restricted stock units.
Summary
- On March 15, 2024, Yakob Liawatidewi disposed of 1,027 shares of Amphastar Pharmaceuticals common stock at a price of $43.05 to cover tax liabilities.
- On March 16, 2024, 1,671 shares were disposed of for the same reason and at the same price.
- On March 17, 2024, a further 1,726 shares were disposed of at $43.05.
- Following these transactions, Liawatidewi directly owns 74,778 shares of common stock and indirectly owns 2,459 shares through the Yakob and Sunmoon Trust.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing relates to routine stock disposals for tax purposes, which is a common practice and doesn't necessarily reflect a change in the executive's outlook on the company.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. Disposals to cover tax obligations are common and don't necessarily indicate a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Disposal of 1,027 shares of Amphastar Pharmaceuticals common stock. |
| 03/16/2024 | Disposal of 1,671 shares of Amphastar Pharmaceuticals common stock. |
| 03/17/2024 | Disposal of 1,726 shares of Amphastar Pharmaceuticals common stock. |
| 03/19/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.